The Anti-snake venom (ASV) is a lifesaving serum, availability of such can prevent number of avoidable deaths occurring due to snake bite every year. The only local source is NIH Islamabad which hardly can produce 1/6th of the actual annual demand of country. The imported sera are high cost with variable effects and most of the time does not neutralize well the venom of the local species.
Having proportionally the highest number of Snake bite cases in Pakistan (20000 to 30000/year) it is one of the most disquieting public health problems of Sindh especially in downtrodden desert districts. The Health Department Government of Sindh requires some special arrangements for adequate and uninterrupted supply of ASV round the year. The experience of past three decades confirmed a doubtful reliance of external sources including NIH. The off time supply and acute shortage during peak time nullifies the efforts and investment of Sindh health department and always leads to unwanted deaths and unrest among masses.
Hence this pivotally important anti sera laboratory gains a high priority in provincial health development plans. The income generation and self reliance aspects of the project ensures a long term sustainability once it is footed to yield it’s product.
In it’s initial phase (Phase-1) the proposed project is configured for production of ASV alone. Gradually it will be expanded to manufacture Anti Rabies, Anti Tetanus, Anti Diphtheria and other Biological products of life saving nature.